Stocktoria

Eurofins Scientific SE ERF.PA

FR · Euronext Paris · XPAR · stock · Healthcare · website

Eurofins Scientific SE statistics & valuation

Market cap€11.9B
P / E25.0×
P / S1.6×
P / B2.6×
P / FCF21.0×
Net margin6.5%
FCF margin7.7%
Net debt€3.6B
Enterprise value USD$17.6B

Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
2022202320242025
Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
2022202320242025
Net debt (€)
2022202320242025
Share buybacks (€)
2022202320242025
Return on assets (%)
2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS (€)
2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Eurofins Scientific SE trades at about 26.8× earnings — near its 10-year norm (10-year range 21.4×–35.7×, median 26.7×).

21.4× 35.7×

Shaded band = 10-year range (21.4×–35.7×); dot = today's 26.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin68.1%67.8%67.0%66.8%
Operating margin11.2%10.4%8.4%11.7%
Net margin6.5%5.8%4.8%9.1%
FCF margin7.7%11.4%7.2%7.1%
Return on assets4.3%3.7%2.8%6.1%
Return on equity10.5%7.6%6.1%12.8%
Debt / equity0.75×0.50×0.57×0.57×
Current ratio1.091.161.451.31

Computed from company filings · FR · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.